Eswar Prasad, senior professor of international trade policy, discusses tariff negotiations between the US and China. 

Natasha Suresh Raheja, assistant professor of anthropology, discusses the relationship between Christians and Hindus in South Asia.

Cynthia Leifer, an immunology professor at Cornell University, voices concern about the negative impact of cutting mRNA vaccine research on pandemic preparedness and medical innovation.

Walter Boot, a psychologist at Weill Cornell Medicine, provides expertise on technology use and cognition among older adults.

“These events that used to be one in 100 [years] or one in 500 are happening back-to-back and that really wears down people’s finances, as well as their mental wherewithal,” says Linda Shi, professor of urban planning.

John Thickstun, assistant professor of computer science, says “I’m not a believer that it’s the end of work and that AI is just going to solve all humanity’s problems for it, but I do think there’s still a lot of headroom for them, and other people in this space, to continue to improve the technology. Not just capitalizing on the gains that have already been made.”

Article mentions 2024 research led by Nicholas Schiff, professor of neuroscience at Weill Cornell Medicine, which suggests that a quarter of patients in vegetative or minimally conscious states show some awareness.

Brian Dunn, director of the Institute for Compensation Studies, discusses Elon Musk remaining the highest-paid CEO in history.

James Patton Rogers, executive director of Cornell University's Tech Policy Institute, discusses the way drones are changing warfare.

“Government policy [has] been the biggest change over the past couple of months,” says Erica Groshen, senior labor market advisor at ILR.

Wendong Zhang, assistant professor of applied economics and policy, discusses import taxes as new tariff rates are implemented.

Julio Giordano, professor of animal science and director of Cornell’s Agricultural Systems Testbed and Demonstration Site for the Farm of the Future—where Labby’s milk-testing startup is currently validating its system—says the technology stands out for its flexibility.